Expert Opinion comprises eleven phase-specific, peer-reviewed journals for pharmaceutical R&D, from drug discovery to pharmacotherapy. Each journal is tailored to the specific phase of the R&D pipeline it focuses on. Typically, you will find in each issue:

• Targeted reviews that assess the current primary research, drawing out the key findings and their applications to clinical practice.
• In-depth drug evaluations that provide neutral assessments of the pharmacological and clinical properties of new compounds.
• Detailed diagnostic and technology evaluations that provide analysis of individual diagnostics and/or technologies revolutionising the field.
• Thought-provoking editorials that survey developments across the discipline and flag up potentially interesting areas for further research.
• Patent evaluations that analyse the aims, chemistry and biological claims of individual patents.
• Original research articles reporting the original results of clinical investigations on agents that are in Phase III and IV clinical trials.

Note: Trial ends Sept. 19, 2008

Please send your comments to Patrick Ellis